Gateway Foundation Alcohol & Drug Treatment’s Dr. Phil Welches Honored by IADDA

Gateway Foundation's Dr. Phil Welches and Michael Darcy

Pictured at the 45th Annual IADDA Fall Conference with the Dr. C. Vincent Bakeman Memorial Award is recipient Gateway Foundation’s Clinical Director Dr. Phil Welches and Gateway Foundation President and CEO Michael Darcy.

Gateway Foundation Alcohol & Drug Treatment, a leading provider of substance abuse treatment, announces today its Clinical Director Dr. Phil Welches received the prestigious Dr. C. Vincent Bakeman Memorial Award at the 45th Annual Illinois Alcoholism and Drug Dependence Association (IADDA) Fall Conference in Lisle, IL, on September 6, 2012. Named after Dr. C. Vincent Bakeman, a pioneer and a visionary in drug addiction treatment and prevention, the award celebrates the work done by Illinois’ leaders in the field of substance abuse services. Recipients of the award are those who have clear vision for the future of the prevention and treatment field, consistently communicate their vision and are tireless leaders dedicated to the advancement of substance abuse treatment and prevention.

“Dr. Welches’ commitment to implementing advancements in the treatment of addiction and his ability to improve the quality of clinical services within the field make him most deserving of the Dr. C. Vincent Bakeman Award. His leadership in integrating evidence-based substance abuse treatment practices and fidelity measures has earned Gateway Foundation a reputation as a leader in providing innovative treatment for substance use disorders,” explains Michael Darcy, President and CEO, Gateway Foundation.

With more than 30 years of experience, Dr. Welches has led efforts to promote concurrent treatment of substance abuse and co-occurring mental health problems. His success in this area of expertise earned him an invitation to participate in the nationwide Collaborative on Dual Diagnosis Capability in Addictions Treatment (DDCAT) chaired by Mark McGovern, Ph.D, of Dartmouth Medical School. Dr. Welches also served as a member of both the DDCAT Measurement Refinement Workgroup and the Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) Measurement Refinement Workgroup, teams that revised the DDCAT and DDCMHT in 2011. Dr. Welches is one of only 10 individuals nationwide who is trained as a trainer on the Dartmouth-developed, Hazelden-published Co-Occurring Disorders Program.

“Mounting research data on treatment effectiveness has helped to change the way we treat addiction. Research has revealed that co-occurring mental health problems are to be expected in addictions treatment. They are the rule, not the exception. Treating co-occurring mental health problems in conjunction with substance use problems within the same program—called ‘integrated treatment’—has proven to be most effective,” says Dr. Phil Welches.

To learn more about Gateway Foundation and its free and confidential consultation, call 877-505-HOPE (4673) or visit RecoverGateway.org.

%d bloggers like this: